ANVISA Plans Public Consultation for E-Cigarette Regulations in Brazil

Regulations by 2FIRSTS.ai
Oct.27.2023
ANVISA Plans Public Consultation for E-Cigarette Regulations in Brazil
Brazil's National Health Surveillance Agency (ANVISA) plans to conduct public consultations on e-cigarettes by the end of the year, as part of a policy revision.

According to a report by Poder 360 on October 26th, Antonio Barra Torres, Director of Brazil's National Health Surveillance Agency (ANVISA), announced that the agency plans to hold a public consultation on the issue of e-cigarettes before the end of this year. This is part of their efforts to revise policies concerning the e-cigarette industry.

 

In an interview, Torres mentioned, "We always prioritize the public interest and strive to improve efficiency in our work as much as possible. Our next plan is to open up public consultations." He emphasized, "Consultations must allow enough time for broad public participation and should aim to complete this phase of work by the end of the current year.

 

Meanwhile, Congress has introduced legislation regarding e-cigarette regulations. During a public hearing held by the Social Affairs Committee on September 28th, proponents argued that a ban on the use of e-cigarettes would increase consumer risks, thus calling for regulation instead. On the other hand, opponents vehemently asserted that e-cigarettes increase the likelihood of individuals experimenting with traditional cigarettes and reiterated the health hazards associated with their usage.

 

Torres stated that the work of the Senate will not expedite the ANVISA approval process.

 

"No matter what happens, our work must be rooted in science," he said.

 

Torres reminded that the Brazilian National Health Surveillance Agency had banned e-cigarettes back in 2009. The agency's latest resolution, unanimously passed since July 2022, maintains the prohibition on the sale of these products.

 

Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.